| Filed On | Filing |
|---|---|
| 15 Jun 2026 |
Form 3: Sawyers Charles Lazelle, Director
Holds 4 shares of Ordinary Shares |
| 15 Jun 2026 |
Form 3: Mooney Elizabeth Fisher, Director
No securities owned |
| 02 Oct 2024 |
Form 3: Sharp Shalini, Director
No securities owned |
| 24 Jul 2024 |
Form 3: Rosenberg Aaron, Chief Financial Officer
No securities owned |
| 26 Mar 2024 |
Form 3: Ball Titus B., Principal Accounting Officer
Holds 23,478 shares of Ordinary Shares |
| 23 Jan 2024 |
Form 3: Brandicourt Olivier, Director
No securities owned |
| 20 Jun 2023 |
Form 3: Lee Chan Henry, SVP, General Counsel
Holds 116,012 shares of Ordinary Shares |
| 08 Feb 2022 |
Form 3: Dugan Margaret, Director
No securities owned |
| 07 Feb 2022 |
Form 3: Riva Alessandro, Director
No securities owned |
| 01 Jul 2021 |
Form 3: Wang Julia Aijun, Chief Financial Officer
Holds 83,876 shares of Ordinary Shares |
| 09 Apr 2021 |
Form 3: Wang Lai, Global Head of R&D
Holds 203,983 shares of Ordinary Shares |
| 26 Aug 2020 |
Form 3: Sanders Corazon (Corsee) D., Director
No securities owned |
| 14 Jul 2020 |
Form 3: Hillhouse Capital ADVISORS, Ltd., 10% owner and 1 other
Holds 147,035,258 shares of Ordinary Shares |
| 23 Mar 2020 |
Form 3: BeiGene, Ltd., 10% owner · Cypherpunk Technologies Inc
Holds 4,804,637 shares of Common Stock |
| 02 Jan 2020 |
Form 3: Hooper Anthony C, Director
No securities owned |
| 02 Jan 2020 |
Form 3: Amgen Inc, 10% owner
Holds 206,635,013 shares of Ordinary Shares |
| 02 May 2018 |
Form 3: Wu Xiaobin, President and GM China
Holds 17,365 shares of American Depositary Shares |
| 04 Apr 2018 |
Form 3: su Jingshyh S, Director
No securities owned |
| 01 Feb 2018 |
Form 3: Hillhouse Capital Management, Ltd., 10% owner
Holds 71,139,367 shares of Ordinary Shares |
| 07 Sep 2016 |
Form 3: Huang Jane, CMO, Hematology
No securities owned |
Loading...
